GLP-1s are not just another diabetes medication
Selective serotonin reuptake inhibitors (SSRIs) : Antidepressants such as fluoxetine or sertraline may help reduce binge frequency, particularly when depression or anxiety co-exists, though they are used off-licence for this indication
GLP-1 (Glucagon-Like Peptide-1) medications are a type of prescription drug that have been gaining attention in the medical community for their potential benefits in managing various health conditions, particularly for women with Polycystic Ovary Syndrome (PCOS)
Abstract We conducted a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database (2005 Q22024 Q3) to evaluate neurological adverse events (NAEs) associated with six glucagon-like peptide-1 receptor agonists (GLP-1 RAs): exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, and tirzepatide
Tirzepatide, a dual GIP/GLP-1 receptor agonist (Mounjaro, Zepbound), has demonstrated even greater weight loss in clinical trials
